RCUS
Price
$9.97
Change
+$0.34 (+3.53%)
Updated
Jun 6 closing price
Capitalization
1.02B
54 days until earnings call
TRDA
Price
$8.32
Change
+$0.20 (+2.46%)
Updated
Jun 6 closing price
Capitalization
307.42M
60 days until earnings call
Interact to see
Advertisement

RCUS vs TRDA

Header iconRCUS vs TRDA Comparison
Open Charts RCUS vs TRDABanner chart's image
Arcus Biosciences
Price$9.97
Change+$0.34 (+3.53%)
Volume$843.75K
Capitalization1.02B
Entrada Therapeutics
Price$8.32
Change+$0.20 (+2.46%)
Volume$92.69K
Capitalization307.42M
RCUS vs TRDA Comparison Chart
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. TRDA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a StrongBuy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (RCUS: $9.13 vs. TRDA: $7.77)
Brand notoriety: RCUS and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 64% vs. TRDA: 84%
Market capitalization -- RCUS: $1.02B vs. TRDA: $307.42M
RCUS [@Biotechnology] is valued at $1.02B. TRDA’s [@Biotechnology] market capitalization is $307.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • RCUS’s TA Score: 5 bullish, 3 bearish.
  • TRDA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than TRDA.

Price Growth

RCUS (@Biotechnology) experienced а +6.04% price change this week, while TRDA (@Biotechnology) price change was +1.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

RCUS is expected to report earnings on Jul 31, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($1.02B) has a higher market cap than TRDA($307M). RCUS YTD gains are higher at: -38.684 vs. TRDA (-55.061). TRDA has higher annual earnings (EBITDA): 50.8M vs. RCUS (-269M). RCUS has more cash in the bank: 978M vs. TRDA (420M). TRDA (59.2M) and RCUS (60M) have identical debt. RCUS has higher revenues than TRDA: RCUS (258M) vs TRDA (211M).
RCUSTRDARCUS / TRDA
Capitalization1.02B307M332%
EBITDA-269M50.8M-530%
Gain YTD-38.684-55.06170%
P/E RatioN/A13.97-
Revenue258M211M122%
Total Cash978M420M233%
Total Debt60M59.2M101%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
84%
Bullish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
76%
Bearish Trend 11 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
75%
Bearish Trend 11 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 25 days ago
83%
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
88%
Aroon
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 11 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with ACLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+1.11%
ACLX - RCUS
47%
Loosely correlated
-1.29%
APGE - RCUS
47%
Loosely correlated
-1.30%
XNCR - RCUS
47%
Loosely correlated
-2.58%
IMNM - RCUS
46%
Loosely correlated
+0.35%
TRDA - RCUS
45%
Loosely correlated
+0.91%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+0.91%
CRNX - TRDA
56%
Loosely correlated
+1.39%
ATXS - TRDA
54%
Loosely correlated
+6.85%
RXRX - TRDA
53%
Loosely correlated
+0.11%
BEAM - TRDA
52%
Loosely correlated
-0.88%
IMNM - TRDA
52%
Loosely correlated
+0.35%
More